5.41% -0.017

Handel nachbörslich: .30 0.003 +1.01%

Theriva Biologics Inc (TOVX)

Überblick Nachrichten Preisverlauf Forum Prognose

Theriva Biologics Inc Aktie (TOVX) Neueste Nachrichten

Theriva Biologics Inc (TOVX)

Theriva Biologics Inc Aktie (TOVX) Neueste Nachrichten

Theriva Biologics (TOVX) Q1 2026 Earnings: Narrowed Loss Beats Expectations as Stock RisesBanking Earnings Report - Newser

TOVX Should I Buy - Intellectia AI

Theriva Biologics (TOVX) Dips 1% as Stock Hovers Near Key Support at $0.28Value Area Low - Newser

Theriva Biologics (TOVX) Hovers Near Support After Modest DeclineCommunity Breakout Alerts - Newser

TOVX Stock Price, Quote & Chart | THERIVA BIOLOGICS INC (NYSEARCA:TOVX) - ChartMill

Theriva Biologics (TOVX) Delivers Q1 2026 Beat — EPS $-0.05 vs $-0.05 ExpectedShared Trade Ideas - Newser

Theriva Biologics (TOVX) Declines -9.35% Amid Market Weakness 2026-05-17Top Analyst Buy Signals - Newser

Theriva Biologics (TOVX) Falls -11.84% — Watching $0.27 Support 2026-05-15Diversification - Newser

BIOLASE Inc (BIOL) - Minichart

TOVX SEC FilingsTHERIVA BIOLOGICS INC 10-K, 10-Q, 8-K Forms - Stock Titan

Maxim Group Maintains Theriva Biologics(TOVX.US) With Buy Rating, Maintains Target Price $1 - Moomoo

Theriva Biologics, Inc. Q1 2026 10-Q Report: Financial Statements, Results, and Key Disclosures - Minichart

Theriva Biologics Reports FDA Alignment on VCN-01 Phase 3 Trial Design for Metastatic Pancreatic Cancer and Q1 2026 Financial Results - Minichart

Theriva Biologics, Inc. 1Q 2026: Revenue $300K, Net income ($2.04M), EPS ($0.05) — 10-Q Summary - TradingView

Theriva™ Biologics Reports First Quarter 2026 Operational Highlights and Financial Results - The Manila Times

Theriva Biologics: Q1 Earnings Snapshot - marketscreener.com

Theriva Biologics (NYSE American: TOVX) posts Q1 loss, flags going concern risk - Stock Titan

Theriva Biologics (NYSE: TOVX) narrows Q1 loss and advances VCN-01 toward pivotal trials - Stock Titan

Theriva moves pancreatic cancer drug toward Phase 3, cash into 2027 - Stock Titan

$Theriva Biologics (TOVX.US)$ - Moomoo

MSN Money - MSN

TOVX Forecast, Price Target & Analyst Ratings | THERIVA BIOLOGICS INC (NYSEARCA:TOVX) - ChartMill

Warrant vote could unlock $8.7M for Theriva Biologics (TOVX) - Stock Titan

TOVX|Theriva Biologics Inc|Price:0.330|Chg%:-0.03 - TradingKey

Theriva Biologics (TOVX) price target decreased by 42.86% to 4.08 - MSN

Trending Stocks Today | Psyence Biomedical Soars 130.26% Pre-Market - Moomoo

Why is Theriva stock gaining Monday? - MSN

symbol__ Stock Quote Price and Forecast - CNN

Press Releases about Theriva Biologics, Inc. Common Stock (NYSE:TOVX) - FinancialContent

Theriva Biologics posts 34.6% EPS beat, no revenueMeet Estimates - Cổng thông tin điện tử tỉnh Lào Cai

Theriva Biologics announces pricing of $7.5M public offering - MSN

Theriva Biologics (TOVX) Comprehensive Review | Theriva Biologics posts 34.6% EPS beat, no revenueBorrow Rate - Cổng thông tin điện tử tỉnh Lào Cai

TOVX (Theriva Biologics Inc.) posts narrower than expected Q4 2025 loss, shares rise four percent on upbeat investor sentiment.Popular Trader Picks - Cổng thông tin điện tử Tỉnh Sơn La

Trending Stocks Today | Theriva Biologics Soars 67.92% Post-Market - 富途牛牛

TOVX Theriva Biologics posts stronger than expected Q4 2025 EPS, shares jump nearly 60 percent in today’s trading session.Turnaround Pick - Newser

Theriva Biologics (NYSE: TOVX) asks shareholders to OK 16.18M warrant shares for $8.7M - Stock Titan

$Theriva Biologics (TOVX.US)$ keep loading on each pullback - Moomoo

Theriva Biologics stock surges on AACR cancer trial data - Investing.com

Theriva Biologics (TOVX) Stock Jumps 63% After Pancreatic Cancer Trial Data Drops at AACR - MEXC Exchange

Theriva Biologics stock surges on AACR cancer trial data By Investing.com - Investing.com UK

$Theriva Biologics (TOVX.US)$ it might be a miracle - Moomoo

Is Theriva Biologics (TOVX) stock breaking out today (Investors Pile In) 2026-04-20IPO Watch - Xã Châu Thành

Why Is Theriva Stock Gaining Monday? - Benzinga

Theriva Biologics (TOVX) Stock Soars 63% on Promising Pancreatic Cancer Data from AACR - MoneyCheck

Theriva Biologics (TOVX) Shares Soar 63% on Promising Pancreatic Cancer Trial Results - parameter.io

Theriva Biologics (TOVX) Stock Soars 63% on Promising Pancreatic Cancer Trial Results - Blockonomi

TOVX Stock Surges 77.6% on AACR Data Presentation, Most Active Today - Meyka

$Theriva Biologics (TOVX.US)$ added more to squeeze 🤞🏼🥳 - Moomoo

Theriva Biologics Presents Positive VIRAGE Phase 2b Clinical Trial Data of VCN-01 for Metastatic Pancreatic Cancer at AACR 2026 - Minichart

Theriva™ Biologics anuncia la próxima presentación de datos adicionales del ensayo clínico VIRAGE de Fase 2b del VCN-01 para el cáncer de páncreas metastásico en la Reunión Anual de la AACR de 2026 - GlobeNewswire Inc.

Ähnlich wie TOVX